Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 3, 2010, Pages 433-438

  Sebastian, Wendy ^a   Roy, Atanu ^b   Kini, Usha ^b   Mullick, Shalini ^b  

^a VIT UNIVERSITY   (India)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Antinuclear antibody test; immune profile; line immunoassay

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE PROTEIN B; DOUBLE STRANDED DNA ANTIBODY; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HISTONE; JO 1 ANTIGEN; MITOCHONDRION ANTIBODY; MITOCHONDRION ANTIBODY M2; NUCLEOLIN; NYLON; PM SCL ANTIGEN; PROTEIN SM; RECOMBINANT ANTIGEN; RIBOSOMAL PROTEIN P; RIBOSOME PROTEIN; RO 52 ANTIGEN; SCL70 ANTIGEN; SSA ANTIGEN; SSB ANTIGEN; UNCLASSIFIED DRUG; AUTOANTIBODY;

ANTIBODY DETECTION; ARTICLE; BIOCHIP; BLOOD SAMPLING; CENTROMERE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSENSUS DEVELOPMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COST; CYTOPLASM; DEVELOPING COUNTRY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; ECONOMIC ASPECT; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; INDIA; INDIAN; LINE IMMUNOASSAY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NUCLEOSOME; POPULATION RESEARCH; PREDICTION; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; BLOOD; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; METHODOLOGY; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; DOUBLE-BLIND METHOD; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; INDIA; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 77955896375     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.68262     Document Type: Article

References (10)

1. Deodhare SG. Autoimmunity and autoimmune diseases. In: Deodhare SG, editor. General Pathology and Pathology of Systems - An integrated approach to Pathology, Microbiology and Clinical Pathology. Revised 6th ed. Mumbai: Popular Prakashan; 2002. p. 586-624.
2. Schur PH, Schmerling RH. Laboratory tests in rheumatic disorders. In: Hochberg MC, Silman A, Smolen J, Weinblatt ME, Weisman M, editors. Rheumatology. 3rd ed. Vol.1. Edinburgh: Mosby; 2003. p. 343-374
3. Peng SL, Craft J. Antinuclear antibodies. In: Ruddy S, Harris ED, Sledge CB, editors. Kelly's Textbook of Rheumatology. 6th ed. Vol.1. Philadelphia: W.B. Saunders Company; 2001, p.161-173
4. Instructions for the Indirect Immunofluorescence test: Mosaic HEp- 20-10/Liver (Monkey) version. EUROIMMUN AG, Germany. Available from: http://www. euroimmun.com [last cited on 2006 Sept 6].
5. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific auto antibodies to nuclear antigens. Arch Pathol Lab Med 2000;124:71-81.
6. Vos PA, Bast EJ, Derksen RH. Cost-effective detection of non-antidouble- stranded DNA antinuclear antibody specificities in daily clinical practice. Rheumatology (Oxford) 2006;45:629-635
7. Sulcebe G, Morcka K. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic disease. Clin Exp Rheumatol 1992;10:255-261
8. Slater CA, Davis RB, Shmerling RH. Antinuclear antibody testing: A study of clinical utility. Arch Intern Med 1996;156:1421-1425
9. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001;60: 1131-1136
10. Hoffman IE, Peene I, Veys EM, De Keyser F. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem 2002;48:2171-2176